"10.1371_journal.pone.0084698","plos one","2014-01-21T00:00:00Z","Jerilynn C Prior; Thomas G Elliott; Eric Norman; Vesna Stajic; Christine L Hitchcock","Centre for Menstrual Cycle and Ovulation Research (CeMCOR), University of British Columbia, Vancouver, British Columbia, Canada; Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; School of Population and Public Health, University of British Columbia and Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada","Conceived and designed the experiments: JCP. Performed the experiments: CLH EN VS. Analyzed the data: CLH. Contributed reagents/materials/analysis tools: TGE CLH. Wrote the paper: JCP CLH. Approved the final manuscript: JCP TGE EN VS CLH.","Initially Schering Canada and subsequently Besins Healthcare provided the oral micronized progesterone and identical placebo as an in-kind donation. There are no further patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Jerilynn C Prior","JCP",5,TRUE,1,3,1,2,TRUE,FALSE,FALSE,0,NA,FALSE
